By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Gulf PressGulf Press
  • Home
  • Gulf News
    • Saudi Arabia
    • UAE24/7
    • Kuwait
    • Qatar
    • Bahrain
    • Oman
  • World
  • Business
    • Market DataLive
    • Finance
    • Economy
    • Energy
    • Crypto
    • ForexHot
    • Tech
  • Sports
  • Lifestyle
  • Videos
Search
Countries
  • Saudi Arabia
  • UAE
  • Kuwait
  • Qatar
  • Bahrain
  • Oman
More Topics
  • Technology
  • Health
  • Entertainment
  • Crypto
  • Forex
  • Stocks
Site Links
  • Business Hub
  • Trending
  • Weather
  • Customize Interests
  • Bookmarks
  • Newsletter
  • Terms
  • Press Release
  • Advertise
  • Contact
© 2023 Gulf Press. All Rights Reserved.
Reading: SGLT-2 inhibitors could reduce the risk of dementia
Share
Notification Show More
Latest News
UAE Ranks Among Top Rugby Markets on TOD as British & Irish Lions Tour Kicks Off
Sports
Darven: A New Leap in AI-Powered Legal Technology Launching from the UAE to the World
Tech
Beat the Heat This Summer with a Chill Out on Dubai Marina
World
Historic Italian City of Assisi to Host International Exhibition “Jordan: Dawn of Christianity”
World
Jordan to Host Iraq in the Final Round of the Asian World Cup Qualifiers After Securing Historic Spot
Sports
Aa
Gulf PressGulf Press
Aa
  • Gulf News
  • World
  • Business
  • Entertainment
  • Lifestyle
  • Sports
  • Videos
Search
  • Home
    • Videos
    • Business Hub
    • Trending
  • Gulf
    • Saudi Arabia
    • UAE
    • Kuwait
    • Qatar
    • Bahrain
    • Oman
  • Business
    • Market Data
    • Crypto
    • Economy
    • Energy
    • Finance
    • Forex
    • Tech
  • More News
    • World
    • Lifestyle
    • Entertainment
    • Sports
Have an existing account? Sign In
Follow US
  • Terms
  • Press Release
  • Advertise
  • Contact
© 2023 Gulf Press. All Rights Reserved.
Gulf Press > Health > SGLT-2 inhibitors could reduce the risk of dementia
Health

SGLT-2 inhibitors could reduce the risk of dementia

News Room
Last updated: 2024/09/02 at 3:45 PM
News Room
Share
4 Min Read
SHARE

A recent study published in The BMJ suggests that a relatively new diabetes drug known as sodium-glucose cotransporter-2 (SGLT-2) inhibitors may reduce the risk of developing dementia in people with type 2 diabetes. The study found that taking SGLT-2 inhibitors was associated with a 35% lower risk of developing dementia compared to taking another common diabetes drug with a different mechanism. The longer an individual had been taking the drug, the greater the protective effect was. Researchers conducted a large-scale observational study using data from the Korean National Health Insurance Service to investigate the link between SGLT-2 inhibitors and dementia risk in people with type 2 diabetes.

The primary risk factor for dementia is aging, and as the average age of the population increases, so does the number of dementia cases. Developing type 2 diabetes is linked to a 50% increase in the risk of developing dementia. People with type 2 diabetes are at a higher risk of dementia due to cardiovascular problems that increase the risk of both conditions, as high blood sugar levels over time can damage blood vessels in the brain, leading to cognitive decline and an increased risk of vascular dementia. Insulin resistance, which is a hallmark of type 2 diabetes, also affects brain cells and is linked to a higher chance of Alzheimer’s disease.

SGLT-2 inhibitors are relatively new drugs that treat type 2 diabetes by preventing the kidneys from reabsorbing as much glucose, allowing the body to remove glucose in urine rather than it re-entering the blood. Currently, around 1 in 10 people in the U.S. with type 2 diabetes take these medications. The study compared people taking SGLT-2 inhibitors with those taking dipeptidyl peptidase-4 (DPP-4) inhibitors and found that participants on SGLT-2 inhibitors had a 35% reduced risk of developing dementia. The risk reduction was most pronounced in those who had been taking SGLT-2 inhibitors for longer periods of more than 2 years compared to less than 2 years.

The authors of the study suggest that SGLT-2 inhibitors might prevent dementia, providing greater benefits with longer treatment. While the effect size may be overestimated due to the observational nature of the study, the results were clear in all subgroups, indicating that the findings are relatively robust. The authors call for randomized controlled trials to confirm the findings. Managing diabetes with medication, maintaining normal blood pressure and blood sugar levels, a healthy body weight, and engaging in physical activity can help reduce the risk of developing dementia in people with type 2 diabetes. Dietary interventions such as reducing alcohol intake and consuming more fiber-rich foods may also reduce risk.

In conclusion, SGLT-2 inhibitors may offer a new potential treatment option for people with type 2 diabetes who are at an increased risk of developing dementia. Future research confirming these findings could help stem the dementia epidemic, especially as the prevalence of both type 2 diabetes and dementia continues to rise. Managing diabetes with medication and making healthy lifestyle changes could significantly reduce a person’s risk of developing dementia, emphasizing the importance of proactive healthcare for individuals with type 2 diabetes.

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
I have read and agree to the terms & conditions
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
News Room September 2, 2024
Share this Article
Facebook Twitter Copy Link Print
Previous Article Malayalam cinema: Actor Siddique approaches Kerala court to seek anticipatory bail in rape case – News
Next Article Tips for Back-to-School Health: Keeping Kids Safe from Seasonal Sicknesses
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Stay Connected

235.3k Followers Like
69.1k Followers Follow
56.4k Followers Follow
136k Subscribers Subscribe
- Advertisement -
Ad imageAd image

Latest News

UAE Ranks Among Top Rugby Markets on TOD as British & Irish Lions Tour Kicks Off
Sports July 6, 2025
Darven: A New Leap in AI-Powered Legal Technology Launching from the UAE to the World
Tech July 1, 2025
Beat the Heat This Summer with a Chill Out on Dubai Marina
World July 1, 2025
Historic Italian City of Assisi to Host International Exhibition “Jordan: Dawn of Christianity”
World June 28, 2025

You Might also Like

Health

Mindfulness could be equally effective as antidepressants

October 17, 2024
Health

What is the impact of caffeine on the risk of developing diseases?

October 17, 2024
Health

Scientists discover combination of 14 genes that enhance outcomes

October 16, 2024
Health

Seizure medication demonstrates potential in individuals with no genetic risk

October 16, 2024
Health

Heart disease increases risk, heparin can postpone onset

October 16, 2024
Health

What type of breakfast is most effective for weight loss in women compared to men?

October 15, 2024
Health

How does the brain remove “waste” to protect itself?

October 14, 2024
Health

How does stress, sleep, and gut imbalances affect it?

October 13, 2024
//

Gulf Press is your one-stop website for the latest news and updates about Arabian Gulf and the world, follow us now to get the news that matters to you.

Quick Link

  • Privacy Policy
  • Terms of ue
  • Advertise
  • Contact

How Topics

  • Gulf News
  • International
  • Business
  • Lifestyle

Sign Up for Our Newsletter

Subscribe to our newsletter to get our latest news instantly!

I have read and agree to the terms & conditions
Gulf PressGulf Press
Follow US

© 2023 Gulf Press. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc..

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?